{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:01Z","timestamp":1787008921944,"version":"build-2736575974"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What structural (logistical) and psychological challenges do patients who cryopreserve oocytes or embryos for medical reasons face, including possible barriers to using their frozen materials?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>The majority of women who underwent oocyte or embryo cryopreservation for medical reasons reported a desire to use their frozen oocytes or embryos but had been impeded by ongoing medical issues, the need for a gestational carrier, or the lack of a partner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Current data suggest that many women who have frozen oocytes or embryos for medical indications are concerned about the prospect of infertility and have unique emotional and financial needs that differ from patients with infertility. Further, most patients have not returned to use their cryopreserved materials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This is a qualitative interview study of 42 people who cryopreserved between January 2012 and December 2021. Interviews were conducted between March 2021 and March 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>All participants were cisgender women who had undergone oocyte or embryo cryopreservation for medical indications at an academic fertility center. Participants were invited to interview by email if they were younger than 40\u2009years old when their oocytes or embryos were cryopreserved. Interviews were conducted over the internet and transcribed verbatim. Data were analyzed using thematic analysis with the constant comparison method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Saturation was reached at 42 interviews. The median age of participants was 35\u2009years old (range 28\u201343) at interview and 31\u2009years old (range 25\u201339) at cryopreservation. Of the 42 women, 30 had a cancer diagnosis, while 7 had non-cancer chronic medical conditions, and 5 had hereditary cancer susceptibility syndromes. There were 12 women who banked embryos and 30 who banked oocytes. The majority of women indicated a desire to use their cryopreserved materials, but many were unsure about how or when. Four had already used their frozen oocytes or embryos, while another four had conceived without assisted reproduction. The cryopreservation experience was described by the majority as highly emotionally challenging because they felt out of place among couples receiving infertility treatment and, for cancer patients, overwhelmed by the complex decisions to be made in a short time period. Common reported barriers to using frozen materials included ongoing medical issues preventing pregnancy, the need for a gestational carrier, the lack of a partner, and the desire for unassisted conception. Some were glad to have frozen oocytes or embryos to allow more time to meet a partner or if they were considering becoming single parents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The majority of participants had their oocytes or embryos frozen at a single, urban, academic fertility center, which may limit generalizability. We also could not calculate a response rate because the snowball technique was used to identify additional participants, so did not know the total number of people invited to participate. Like other interview studies, our study may be subject to response bias because those who agreed to participate may have particularly positive or negative views about their experiences. Furthermore, the mean follow-up time since freezing was relatively short (3.3\u2009years, median 2.7\u2009years), which may not have been enough time for some patients to use their frozen materials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Learning about the experiences of patients undergoing medically indicated oocyte and embryo cryopreservation can help clinicians better counsel these patients regarding decisions and hurdles they may encounter. We found that most patients had not returned to use their frozen materials because of ongoing medical issues, the need for a gestational carrier, lack of a partner, or the desire to attempt unassisted reproduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>This study did not receive any funding. The authors of this study have no conflicts of interest to declare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/dead228","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:39:47Z","timestamp":1698165587000},"page":"147-153","source":"Crossref","is-referenced-by-count":11,"title":["Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-5188","authenticated-orcid":false,"given":"M J","family":"Bayefsky","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, New York University Langone Health , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sampson","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey School of Medicine , Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8586-4232","authenticated-orcid":false,"given":"J K","family":"Blakemore","sequence":"additional","affiliation":[{"name":"New York University Langone Fertility Center, Department of Obstetrics and Gynecology, New York University Langone Health , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Jalili","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, New York University Langone Health , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Lilly","sequence":"additional","affiliation":[{"name":"Vanderbilt University , Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Fino","sequence":"additional","affiliation":[{"name":"New York University Langone Fertility Center, Department of Obstetrics and Gynecology, New York University Langone Health , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-9889","authenticated-orcid":false,"given":"G P","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, New York University Langone Health , New York, NY, USA"},{"name":"Department of Population Health, New York University Grossman School of Medicine , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"2024010511463775100_dead228-B1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/1600910X.2015.1091780","article-title":"Psychological IVF: conceptualizing emotional choreography in a fertility clinic","volume":"16","author":"Adrian","year":"2015","journal-title":"Distinktion"},{"key":"2024010511463775100_dead228-B2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10815-013-0024-z","article-title":"Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation","volume":"30","author":"Barcroft","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2024010511463775100_dead228-B3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/cancers13061355","article-title":"How do young women with cancer experience oncofertility counselling during cancer treatment? A qualitative, single centre study at a Danish tertiary hospital","volume":"13","author":"Bentsen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024010511463775100_dead228-B4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.fertnstert.2022.04.013","article-title":"Fifteen years of autologous oocyte thaw outcomes from a large university-based fertility center","volume":"118","author":"Cascante","year":"2022","journal-title":"Fertil Steril"},{"key":"2024010511463775100_dead228-B5","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/humrep\/deu137","article-title":"Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study","volume":"29","author":"Dahhan","year":"2014","journal-title":"Hum Reprod"},{"key":"2024010511463775100_dead228-B6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10815-015-0533-z","article-title":"Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment","volume":"32","author":"Dolmans","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2024010511463775100_dead228-B7","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"4","author":"ESHRE Guideline Group on Female Fertility Preservation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2024010511463775100_dead228-B8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7748\/ns2001.07.15.42.39.c3052","article-title":"Use of constant comparative analysis in qualitative research","volume":"15","author":"Hewitt-Taylor","year":"2001","journal-title":"Nurs Stand"},{"key":"2024010511463775100_dead228-B9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2013.07.201","article-title":"What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?","volume":"100","author":"Hodes-Wertz","year":"2013","journal-title":"Fertil Steril"},{"key":"2024010511463775100_dead228-B10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.socscimed.2017.10.031","article-title":"Medical oocyte freezing and cancer patients\u2019 hopes: Fertility preservation at the intersection of life and death","volume":"195","author":"Inhorn","year":"2017","journal-title":"Soc Sci Med"},{"key":"2024010511463775100_dead228-B11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10815-017-1081-5","article-title":"Medical oocyte freezing: the importance of a patient-centered approach to fertility preservation","volume":"35","author":"Inhorn","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"2024010511463775100_dead228-B12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.rbms.2017.12.001","article-title":"Medical oocyte freezing: how cost and lack of insurance cover impact women and their families","volume":"5","author":"Inhorn","year":"2018","journal-title":"Reprod Biomed Soc Online"},{"key":"2024010511463775100_dead228-B13","author":"Livestrong Fertility"},{"key":"2024010511463775100_dead228-B14","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024010511463775100_dead228-B15","doi-asserted-by":"crossref","first-page":"e2010806","DOI":"10.1001\/jamanetworkopen.2020.10806","article-title":"Evaluation of reported fertility preservation counseling before chemotherapy using the quality oncology practice initiative survey","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024010511463775100_dead228-B16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3138\/ijfab.12.2.02","article-title":"\u201cBeing guided\u201d: what oncofertility patient\u2019s decisions can teach us about the efficacy of autonomy, agency, and decision-making theory in the contemporary clinical encounter","volume":"12","author":"Paton","year":"2019","journal-title":"Int J Fem Approaches Bioeth"},{"key":"2024010511463775100_dead228-B17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/humrep\/dex356","article-title":"Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?","volume":"33","author":"Peccatori","year":"2018","journal-title":"Hum Reprod"},{"key":"2024010511463775100_dead228-B18","doi-asserted-by":"crossref","first-page":"pkz008","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"2024010511463775100_dead228-B19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2019","journal-title":"Fertil Steril"},{"key":"2024010511463775100_dead228-B20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/sf\/soy098","article-title":"Childless expectations and childlessness over the life course","volume":"97","author":"Rybi\u0144ska","year":"2019","journal-title":"Soc Forces"},{"key":"2024010511463775100_dead228-B21","doi-asserted-by":"crossref","first-page":"103604","DOI":"10.1016\/j.critrevonc.2022.103604","article-title":"Fertility counseling in women with hereditary cancer syndromes","volume":"171","author":"Somigliana","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024010511463775100_dead228-B22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12958-021-00884-0","article-title":"Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation","volume":"20","author":"Walker","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2024010511463775100_dead228-B23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00520-019-04883-1","article-title":"Supportive oncofertility care, psychological health and reproductive concerns: a qualitative study","volume":"28","author":"Wang","year":"2020","journal-title":"Support Care Cancer"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/1\/147\/54909736\/dead228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/1\/147\/54909736\/dead228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T07:20:35Z","timestamp":1704439235000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/1\/147\/7379810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,7]]},"published-print":{"date-parts":[[2024,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead228","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,11,7]]}}}